Trial Profile
An Open Label, Single Dose, Parallel Group Study to Evaluate Absorption and Transit Characteristics of TREXIMA and RELPAX in Patients Inside and Outside of an Acute Migraine Attack.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Eletriptan
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 23 Sep 2010 Trial phase changed from III to I as reported by ClinicalTrials.gov.
- 18 Sep 2008 New trial record.